2
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Other solid neoplasm
2
Gynecologic
2
Gastrointestinal
2
Sarcoma
1
Conditions
Stomach Neoplasms
34
Ovarian Neoplasms
31
Peritoneal Neoplasms
28
Fallopian Tube Neoplasms
14
Colorectal Neoplasms
14
Carcinoma, Ovarian Epithelial
13
Appendiceal Neoplasms
7
Neoplasm Metastasis
5
Pancreatic Neoplasms
4
Uterine Neoplasms
3
Recurrence
3
Pseudomyxoma Peritonei
3
Neoplasms
3
Carcinoma
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Peritoneal Diseases
2
Mesothelioma, Malignant
2
Mesothelioma
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gastrointestinal Neoplasms
2
Gastric Adenocarcinoma
2
Desmoplastic Small Round Cell Tumor
2
Colonic Neoplasms
2
Wilms Tumor
1
Stomach Diseases
1
Stage â…¢ Gastric Cancer
1
Stage IV Gastric Cancer With Metastasis
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Interventions
Cisplatin
57
Pemetrexed
46
pembrolizumab
18
Nivolumab
15
Carboplatin
15
Gemcitabine
14
Cyclophosphamide
13
Radiotherapy
10
Drug Therapy
9
atezolizumab
8
Platinum
7
Ipilimumab
7
Doxorubicin
7
durvalumab
6
1,2-diaminocyclohexaneplatinum II citrate
6
tremelimumab
5
sodium thiosulfate
5
Vinorelbine
5
Radiotherapy, Intensity-Modulated
5
Interleukin-2
5
Chemotherapy, Adjuvant
5
Cerebral Decortication
5
sargramostim
4
fludarabine
4
defactinib
4
aldesleukin
4
tumor necrosis factor-alpha, CNGRC fusion protein, human
3
cediranib
3
Photochemotherapy
3
Neoadjuvant Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Hyperthermic Intraperitoneal Chemotherapy
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled
NCT03210298
2019-10-08
PIPACRegis
University of Magdeburg
Unknown
1,000 enrolled